UNIMYET

Serial Number 98454144
688

Registration Progress

Application Filed
Mar 18, 2024
Under Examination
Mar 25, 2025
Approved for Publication
Jan 28, 2025
Published for Opposition
Jan 28, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Sep 25, 2025 67 days

Trademark Image

UNIMYET

Basic Information

Serial Number
98454144
Filing Date
March 18, 2024
Published for Opposition
January 28, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Mar 25, 2025
Application
Pending
Classes
042

Rights Holder

LTZ Therapeutics Inc.

03
Address
1100 Island Dr., Suite 103
Redwood City, CA 94065

Ownership History

LTZ Therapeutics Inc.

Original Applicant
03
Redwood City, CA

LTZ Therapeutics Inc.

Owner at Publication
03
Redwood City, CA

Legal Representation

Attorney
Enshan Hong

USPTO Deadlines

Next Deadline
67 days remaining
NOA E-Mailed - SOU Required
Due Date
September 25, 2025
Extension Available
Until March 25, 2026

Application History

14 events
Date Code Type Description Documents
Mar 25, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 28, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 28, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 22, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 2, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 6, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 6, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 6, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 3, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 3, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 3, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 26, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 12, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 18, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; drug discovery services, namely, the development of novel therapeutics for the treatment of multiple diseases;drug discovery services, namely, the development of novel therapeutics for treatment of cancer, autoimmune and infectious diseases.

Classification

International Classes
042